
Nizal S. Chandrakumar
Examiner (ID: 111, Phone: (571)272-6202 , Office: P/1625 )
| Most Active Art Unit | 1625 |
| Art Unit(s) | 1625 |
| Total Applications | 2819 |
| Issued Applications | 1922 |
| Pending Applications | 209 |
| Abandoned Applications | 730 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 12904465
[patent_doc_number] => 20180193330
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-12
[patent_title] => ALKYLATED TETRAHYDROISOQUINOLINES FOR BINDING TO CENTRAL NERVOUS SYSTEM RECEPTORS
[patent_app_type] => utility
[patent_app_number] => 15/861750
[patent_app_country] => US
[patent_app_date] => 2018-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20624
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 126
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15861750
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/861750 | Alkylated tetrahydroisoquinolines for binding to central nervous system receptors | Jan 3, 2018 | Issued |
Array
(
[id] => 12675487
[patent_doc_number] => 20180116995
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-03
[patent_title] => BICYCLIC COMPOUND AND USE THEREOF FOR MEDICAL PURPOSES
[patent_app_type] => utility
[patent_app_number] => 15/852493
[patent_app_country] => US
[patent_app_date] => 2017-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27693
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15852493
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/852493 | Bicyclic compound and use thereof for medical purposes | Dec 21, 2017 | Issued |
Array
(
[id] => 18443114
[patent_doc_number] => 11678661
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-06-20
[patent_title] => Thickened organic liquid compositions with polymeric rheology modifiers
[patent_app_type] => utility
[patent_app_number] => 16/473738
[patent_app_country] => US
[patent_app_date] => 2017-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20966
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 122
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16473738
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/473738 | Thickened organic liquid compositions with polymeric rheology modifiers | Dec 20, 2017 | Issued |
Array
(
[id] => 12857728
[patent_doc_number] => 20180177750
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-28
[patent_title] => COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF ENHANCER OF ZESTE HOMOLOG 2 POLYPEPTIDE
[patent_app_type] => utility
[patent_app_number] => 15/851053
[patent_app_country] => US
[patent_app_date] => 2017-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 67636
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15851053
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/851053 | Compounds and methods for the targeted degradation of enhancer of zeste homolog 2 polypeptide | Dec 20, 2017 | Issued |
Array
(
[id] => 14501163
[patent_doc_number] => 20190194236
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-27
[patent_title] => Organometallic Antibiotics
[patent_app_type] => utility
[patent_app_number] => 15/851696
[patent_app_country] => US
[patent_app_date] => 2017-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2666
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15851696
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/851696 | Organometallic Antibiotics | Dec 20, 2017 | Abandoned |
Array
(
[id] => 17727682
[patent_doc_number] => 11384056
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-07-12
[patent_title] => Method for the manufacturing of delmopinol intermediates
[patent_app_type] => utility
[patent_app_number] => 16/472476
[patent_app_country] => US
[patent_app_date] => 2017-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6145
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16472476
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/472476 | Method for the manufacturing of delmopinol intermediates | Dec 19, 2017 | Issued |
Array
(
[id] => 15177981
[patent_doc_number] => 20190359582
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-28
[patent_title] => PROCESS FOR PRODUCING A TETRAHYDROFURAN COMPOUND COMPRISING AT LEAST TWO AMINE FUNCTIONAL GROUPS
[patent_app_type] => utility
[patent_app_number] => 16/472365
[patent_app_country] => US
[patent_app_date] => 2017-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4416
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16472365
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/472365 | PROCESS FOR PRODUCING A TETRAHYDROFURAN COMPOUND COMPRISING AT LEAST TWO AMINE FUNCTIONAL GROUPS | Dec 14, 2017 | Abandoned |
Array
(
[id] => 15454291
[patent_doc_number] => 20200039970
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-06
[patent_title] => HYDANTOIN MODULATORS OF KV3 CHANNELS
[patent_app_type] => utility
[patent_app_number] => 16/469472
[patent_app_country] => US
[patent_app_date] => 2017-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17905
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16469472
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/469472 | HYDANTOIN MODULATORS OF KV3 CHANNELS | Dec 14, 2017 | Abandoned |
Array
(
[id] => 15193819
[patent_doc_number] => 10494388
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-12-03
[patent_title] => Compounds useful in the synthesis of halichondrin B analogs
[patent_app_type] => utility
[patent_app_number] => 15/840109
[patent_app_country] => US
[patent_app_date] => 2017-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11016
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 311
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15840109
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/840109 | Compounds useful in the synthesis of halichondrin B analogs | Dec 12, 2017 | Issued |
Array
(
[id] => 12837169
[patent_doc_number] => 20180170896
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-21
[patent_title] => METHODS OF PREPARING OXA-BICYCLOALKENE
[patent_app_type] => utility
[patent_app_number] => 15/838455
[patent_app_country] => US
[patent_app_date] => 2017-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3955
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15838455
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/838455 | Methods of preparing oxa-bicycloalkene | Dec 11, 2017 | Issued |
Array
(
[id] => 16222656
[patent_doc_number] => 20200247772
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-06
[patent_title] => Production of 11-hydroxy-thc
[patent_app_type] => utility
[patent_app_number] => 15/732670
[patent_app_country] => US
[patent_app_date] => 2017-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1134
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15732670
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/732670 | Production of 11-hydroxy-thc | Dec 11, 2017 | Abandoned |
Array
(
[id] => 16353046
[patent_doc_number] => 10793547
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-10-06
[patent_title] => Modulator of the cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator
[patent_app_type] => utility
[patent_app_number] => 15/836627
[patent_app_country] => US
[patent_app_date] => 2017-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 17
[patent_no_of_words] => 72537
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15836627
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/836627 | Modulator of the cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator | Dec 7, 2017 | Issued |
Array
(
[id] => 15116941
[patent_doc_number] => 20190345103
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-14
[patent_title] => FUSED BICYCLIC ALKYLENE LINKED IMIDODICARBONIMIDIC DIAMIDES, METHODS FOR SYNTHESIS, AND USES IN THERAPY
[patent_app_type] => utility
[patent_app_number] => 16/467136
[patent_app_country] => US
[patent_app_date] => 2017-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23910
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -58
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16467136
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/467136 | Fused bicyclic alkylene linked imidodicarbonimidic diamides, methods for synthesis, and uses in therapy | Dec 6, 2017 | Issued |
Array
(
[id] => 15116991
[patent_doc_number] => 20190345128
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-14
[patent_title] => PROCESSES FOR OBTAINING PURIFIED UNSATURATED MACROCYCLIC COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 16/466643
[patent_app_country] => US
[patent_app_date] => 2017-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21909
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16466643
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/466643 | Processes for obtaining purified unsaturated macrocyclic compounds | Dec 4, 2017 | Issued |
Array
(
[id] => 16940993
[patent_doc_number] => 11053214
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-07-06
[patent_title] => Compositions and methods related to pyridinoylpiperidine 5-HT
[patent_app_type] => utility
[patent_app_number] => 16/467208
[patent_app_country] => US
[patent_app_date] => 2017-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 12134
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16467208
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/467208 | Compositions and methods related to pyridinoylpiperidine 5-HT | Dec 4, 2017 | Issued |
Array
(
[id] => 14993499
[patent_doc_number] => 20190315707
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-17
[patent_title] => PREPARATION METHOD FOR TRICYCLIC COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 16/467101
[patent_app_country] => US
[patent_app_date] => 2017-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8589
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 288
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16467101
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/467101 | Preparation method for tricyclic compounds | Dec 3, 2017 | Issued |
Array
(
[id] => 16784968
[patent_doc_number] => 10987367
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-04-27
[patent_title] => Drug targets of delayed aging and human brain diseases
[patent_app_type] => utility
[patent_app_number] => 16/463904
[patent_app_country] => US
[patent_app_date] => 2017-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 19
[patent_no_of_words] => 16054
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16463904
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/463904 | Drug targets of delayed aging and human brain diseases | Nov 27, 2017 | Issued |
Array
(
[id] => 16353038
[patent_doc_number] => 10793539
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-10-06
[patent_title] => Process for the preparation of tocols and squalene
[patent_app_type] => utility
[patent_app_number] => 16/466843
[patent_app_country] => US
[patent_app_date] => 2017-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3299
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 264
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16466843
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/466843 | Process for the preparation of tocols and squalene | Nov 26, 2017 | Issued |
Array
(
[id] => 16925232
[patent_doc_number] => 11046693
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-06-29
[patent_title] => Pyrido-phenanthroline derivatives, production and use thereof as medicaments
[patent_app_type] => utility
[patent_app_number] => 16/465258
[patent_app_country] => US
[patent_app_date] => 2017-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 5
[patent_no_of_words] => 4462
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16465258
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/465258 | Pyrido-phenanthroline derivatives, production and use thereof as medicaments | Nov 23, 2017 | Issued |
Array
(
[id] => 18518501
[patent_doc_number] => 11708381
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-07-25
[patent_title] => Inhibitors of androgen receptor signaling
[patent_app_type] => utility
[patent_app_number] => 16/463135
[patent_app_country] => US
[patent_app_date] => 2017-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 12
[patent_no_of_words] => 4866
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16463135
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/463135 | Inhibitors of androgen receptor signaling | Nov 21, 2017 | Issued |